Literature DB >> 6488906

Enlarged pulmonary arteriovenous vessels in COPD. Another possible mechanism of hypoxemia.

W C Miller, J G Heard, K M Unger.   

Abstract

Among 27 patients with moderate-to-severe chronic obstructive lung disease, 22 had anatomic intrapulmonary shunting greater than that seen in normal subjects. The shunted blood passed through enlarged pulmonary vessels, as demonstrated with particles 10-90 microns in diameter. The shunt magnitude was correlated with the decrement in lung diffusing capacity. It did not correlate well with pulmonary mechanical abnormalities such as air flows and volumes or resting blood gas data. Nevertheless, shunting through enlarged pulmonary vessels may play a role in the hypoxemia seen in COPD patients, especially at exercise.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488906     DOI: 10.1378/chest.86.5.704

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Patent Foramen Ovale in COPD and Hypoxia: Innocent Bystander or Novel Therapeutic Target?

Authors:  Brett E Fenster; John D Carroll
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

2.  Platypnoea-orthodeoxia syndrome: novel cause for a known condition.

Authors:  Rajendra Takhar; Rakesh Biswas; Ashish Arora; Vipin Jain
Journal:  BMJ Case Rep       Date:  2014-03-07

3.  Anatomical lung shunting in pulmonary fibrosis.

Authors:  W C Miller; J G Heard; K M Unger; D M Suich
Journal:  Thorax       Date:  1986-03       Impact factor: 9.139

4.  Massive paradoxical air embolism in brain occurring after central venous catheterization: a case report.

Authors:  Seon-Sook Han; Sam Soo Kim; Hyun Pyo Hong; Seo-Young Lee; Seung-Joon Lee; Bong-Ki Lee
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

5.  Plasma orexin-a levels in COPD patients with hypercapnic respiratory failure.

Authors:  Lin-Yun Zhu; Hanssa Summah; Hong-Ni Jiang; Jie-Ming Qu
Journal:  Mediators Inflamm       Date:  2011-05-26       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.